https://www.selleckchem.com/products/icfsp1.html
parameters.Trial Registration The study was retrospectively registered in the NIH registry. Registration number is pending.Alternatives to daily dosing of HIV pre-exposure prophylaxis (PrEP) are continuing to emerge. From October 2019 to March 2020, we conducted an online survey of PrEP-experienced gay and bisexual men in Australia about interest in and preference for four different PrEP modalities daily dosing, event-driven dosing, long-acting injectable (LAI)-PrEP and subdermal PrEP implants. Using data from 1477 participants, we measu
إعجاب
علق
شارك
